Lower gastrointestinal diseases affect the colon, rectum, and anus — a spectrum ranging from functional disorders (IBS affects ~10–15% of the global population) to life-threatening malignancies (colorectal cancer is the 3rd most common cancer worldwide, with 1.9 million new cases per year). Colonoscopy is the cornerstone of lower GI diagnosis and treatment — enabling direct visualisation, biopsy, polyp removal (polypectomy, EMR, ESD), and therapeutic interventions including balloon dilation for Crohn's strictures. This guide covers the major lower GI conditions, colonoscopic procedures, and management strategies aligned with BSG, ESGE, and ECCO guidelines.
Overview of Lower GI Diseases
The lower gastrointestinal tract comprises the small intestine (jejunum and ileum), the large intestine (colon), the rectum, and the anus. Diseases affecting this region range from common functional disorders like irritable bowel syndrome (IBS) to serious conditions including colorectal cancer, inflammatory bowel disease (IBD), and diverticular disease.
Colonoscopy — a flexible camera examination of the entire colon — is the gold-standard diagnostic and therapeutic tool for lower GI disease. It allows direct visualisation of the colonic mucosa, biopsy of suspicious lesions, and removal of polyps before they become cancerous.
When to see a doctor
Rectal bleeding, persistent change in bowel habits, unexplained weight loss, abdominal pain lasting more than a few weeks, or anaemia without obvious cause should all prompt prompt medical evaluation.
Lower GI pathology encompasses neoplastic, inflammatory, functional, vascular, and structural disease. Risk stratification tools — including the FIT (faecal immunochemical test), NICE DG30 guidelines, and Manchester scoring — guide appropriate investigation pathways. Colonoscopy remains the definitive tool; however, CT colonography (virtual colonoscopy) is an accepted alternative in patients unfit for or declining optical colonoscopy. Capsule colonoscopy and AI-assisted adenoma detection are emerging adjuncts.
| Condition | Category | Key Investigation | Colonoscopy Role |
|---|---|---|---|
| Colorectal Cancer | Neoplastic | Colonoscopy + biopsy, CT staging, CEA | Diagnosis, tattooing, palliative stenting |
| Colorectal Polyps | Pre-neoplastic | Colonoscopy | Polypectomy (snare, EMR, ESD) |
| Crohn's Disease | Inflammatory (IBD) | Colonoscopy + ileoscopy, MRE, CRP, calprotectin | Diagnosis, surveillance, stricture dilation |
| Ulcerative Colitis | Inflammatory (IBD) | Colonoscopy + biopsy, calprotectin, CRP | Diagnosis, dysplasia surveillance |
| Diverticular Disease | Structural | CT abdomen, colonoscopy (elective) | Diagnosis, haemostasis for bleeding |
| IBS | Functional | Clinical (Rome IV criteria); exclusion of organic disease | Exclusion of IBD / malignancy |
Anatomy of the Lower GI Tract
Small Intestine
6–7 metres long; divided into duodenum, jejunum, and ileum. Primary site of nutrient absorption. Crohn's disease frequently affects the terminal ileum.
Colon (Large Intestine)
~1.5 metres long; divided into ascending, transverse, descending, and sigmoid segments. Absorbs water and electrolytes; forms and stores faeces. Most colorectal cancers arise here.
Rectum
The final 15 cm of the large bowel before the anus. Stores faeces before defecation. Rectal cancer has distinct treatment pathways from colon cancer, including neoadjuvant chemoradiotherapy.
Caecum & Appendix
The caecum is the junction between small and large intestine. The appendix is a small pouch arising from the caecum; appendicitis is one of the most common surgical emergencies.
Clinical Note — Colonoscopic Landmarks
Complete colonoscopy is defined by caecal intubation, confirmed by visualisation of the appendiceal orifice and ileocaecal valve, ideally supplemented by photodocumentation. The hepatic and splenic flexures are technically demanding; right-sided colon (ascending + caecum) harbours a disproportionate share of interval cancers — often flat or sessile serrated lesions missed on inadequate withdrawal. Withdrawal time ≥6 minutes is strongly correlated with adenoma detection rate (ADR). The ADR benchmark is ≥25% (≥20% in women, ≥30% in men) per BSG / ESGE quality standards.
Colorectal Cancer (CRC)
Colorectal cancer (CRC) is cancer of the colon or rectum. It is the third most common cancer worldwide and the second leading cause of cancer-related death. The good news is that it is one of the most preventable and treatable cancers when caught early — which is why screening programmes are so important.
Most colorectal cancers develop slowly over many years from benign growths called polyps. Regular colonoscopy screening allows these polyps to be detected and removed before they become cancerous — effectively preventing the disease from developing.
CRC staging follows the TNM system (UICC/AJCC 8th edition) and is complemented by the Dukes classification. MSI (microsatellite instability) and KRAS/NRAS/BRAF mutational status are mandatory for metastatic CRC to guide immunotherapy and anti-EGFR therapy eligibility. Lynch syndrome (hereditary non-polyposis colorectal cancer) accounts for 3–5% of all CRC; universal MMR/MSI testing of all CRC specimens is recommended by ESGE and BSG.
Warning Signs
Symptoms to Watch For
- Rectal bleeding or blood in stool
- Persistent change in bowel habits (>3 weeks)
- Unexplained weight loss
- Abdominal pain or bloating
- Feeling of incomplete bowel emptying
- Iron-deficiency anaemia (fatigue, pallor)
Key Risk Factors
- Age over 50
- Family history of CRC or polyps
- Personal history of polyps or IBD
- Hereditary syndromes (Lynch, FAP)
- High-red-meat / processed-meat diet
- Obesity, physical inactivity, smoking, alcohol
| TNM Stage | Dukes | Description | 5-yr Survival |
|---|---|---|---|
| I | A | Confined to bowel wall (submucosa or muscularis propria) | ~90% |
| II | B | Through bowel wall, no node involvement | ~75% |
| III | C | Regional lymph node involvement | ~50% |
| IV | D | Distant metastases (liver, lung, peritoneum) | ~14% |
Colorectal Polyps
Colorectal polyps are small growths on the inner lining of the colon or rectum. Most are harmless, but certain types — particularly adenomatous polyps — can slowly become cancerous over 10–15 years if left untreated. Removing them during colonoscopy (polypectomy) is one of the most effective cancer-prevention strategies available.
🔬
Tubular Adenoma
Most common; low-grade dysplasia; low cancer risk if small
⚠️
Villous Adenoma
Higher malignant potential; often sessile and larger
🧬
Sessile Serrated Lesion
Flat, right-sided; responsible for many interval cancers; easily missed
✅
Hyperplastic Polyp
Generally benign; no surveillance required if small and distal
Post-Polypectomy Surveillance — BSG 2020 Guidelines
| Risk Category | Finding | Surveillance Interval |
|---|---|---|
| Low | 1–2 adenomas <10 mm, low-grade dysplasia | No surveillance; return to population screening |
| Intermediate | 3–4 small adenomas, or 1–2 adenomas ≥10 mm | 3 years |
| High | ≥5 adenomas, or ≥1 adenoma ≥20 mm, or any HGD | 1 year |
| Serrated | SSL ≥10 mm or with dysplasia; ≥3 SSLs | 3 years |
Inflammatory Bowel Disease (IBD)
Inflammatory bowel disease (IBD) is a term for two chronic conditions that cause inflammation of the digestive tract: Crohn's disease and ulcerative colitis (UC). IBD is a lifelong condition that follows a relapsing-remitting course. While there is currently no cure, effective treatments can control symptoms and achieve long-term remission.
Crohn's Disease
- Can affect any part of the GI tract (mouth to anus)
- Transmural inflammation; skip lesions; cobblestone appearance
- Symptoms: diarrhoea, abdominal cramps, weight loss, fatigue
- Complications: strictures, fistulae, abscesses, perianal disease
- Endoscopic balloon dilation used for short fibrostenotic strictures
Ulcerative Colitis
- Confined to the colon and rectum; always involves the rectum
- Mucosal inflammation only; continuous involvement
- Symptoms: bloody diarrhoea, urgency, tenesmus, cramping
- Complications: toxic megacolon, fulminant colitis, dysplasia / CRC
- CRC surveillance colonoscopy from 8–10 years after diagnosis
IBD Therapy Ladder & Biologics
| Step | Drugs | Indication |
|---|---|---|
| 1st line | 5-ASA (mesalazine) — UC; corticosteroids (induction) | Mild-moderate UC; induction of remission |
| 2nd line | Azathioprine, 6-MP, methotrexate | Steroid-dependent / chronic active disease |
| 3rd line | Anti-TNF (infliximab, adalimumab), vedolizumab, ustekinumab, JAK inhibitors | Moderate-severe IBD refractory to immunomodulators |
| Surgery | Colectomy (UC), resection / strictureplasty (Crohn's) | Medically refractory disease, complications, dysplasia, CRC |
Diverticular Disease
Diverticula are small pouches that bulge outward through weak spots in the colon wall. Having these pouches — diverticulosis — is very common and usually causes no problems. Diverticulitis occurs when one or more of the pouches becomes inflamed or infected, causing pain and other symptoms.
Diverticulosis
Presence of diverticula without inflammation. Affects >50% of people over 70. Often asymptomatic — discovered incidentally during colonoscopy.
Acute Diverticulitis
Inflammation / infection of diverticula. Left iliac fossa pain, fever, altered bowel habit. CT abdomen is the diagnostic standard. Treated with antibiotics ± surgery for complications.
Diverticular Bleeding
Most common cause of significant lower GI bleeding in the elderly. Usually painless, right-sided, and self-limiting. Colonoscopy + haemostasis (clip, thermal) for persistent bleeding.
Prevention & Management
Irritable Bowel Syndrome (IBS)
IBS is a common functional bowel disorder characterised by abdominal pain associated with altered bowel habits (diarrhoea, constipation, or both) in the absence of structural or biochemical abnormalities. It affects up to 10–15% of the global population and significantly impairs quality of life.
IBS is a diagnosis of exclusion — meaning other serious conditions must be ruled out first. Colonoscopy may be recommended to exclude IBD, microscopic colitis, or colorectal cancer, particularly in patients with alarm features (rectal bleeding, weight loss, age >45 at onset, family history of CRC).
IBS is diagnosed using Rome IV criteria: recurrent abdominal pain ≥1 day/week for the last 3 months, associated with ≥2 of: related to defecation; associated with change in stool frequency; associated with change in stool form. Subtypes: IBS-D (diarrhoea-predominant), IBS-C (constipation-predominant), IBS-M (mixed), IBS-U (unsubtyped). Investigation: FBC, CRP, tTG-IgA (coeliac serology), faecal calprotectin (<50 µg/g has high NPV for IBD). Colonoscopy indicated if FCP elevated or alarm features present.
Dietary Management
- • Low-FODMAP diet (first-line dietary intervention)
- • Regular meal timing; avoid large meals
- • Reduce caffeine, alcohol, and carbonated drinks
- • Soluble fibre for IBS-C; avoid insoluble fibre in IBS-D
- • Probiotics: limited but emerging evidence
Pharmacological Options
- • Antispasmodics (mebeverine, hyoscine) — abdominal cramps
- • Loperamide — IBS-D symptom control
- • Laxatives (macrogol) — IBS-C
- • Low-dose tricyclic antidepressants — pain modulation
- • Linaclotide / plecanatide — IBS-C (NICE-approved)
Colonoscopy & Diagnosis: Polypectomy, EMR, ESD & Balloon Dilation
Colonoscopy is the most thorough way to examine the entire colon. A thin flexible tube with a camera and light is guided through the rectum and colon while the patient is under mild sedation. Polyps found during the procedure can often be removed immediately. The preparation involves bowel cleansing the day before with a laxative solution.
Optical Colonoscopy
Gold standard; diagnostic and therapeutic in the same session
CT Colonography
Non-invasive alternative; no biopsy capability; detects polyps ≥6 mm
FIT / Stool Testing
Non-invasive screening; positive result triggers colonoscopy referral
Endoscopic Resection Techniques
| Technique | Indication | Key Points |
|---|---|---|
| Cold snare polypectomy | Polyps <10 mm (especially <5 mm) | No electrocautery; lower bleeding risk; preferred for SSLs |
| Hot snare polypectomy | Pedunculated polyps 10–20 mm | Electrocautery; risk of delayed bleeding; clip prophylaxis for large stalks |
| EMR (Endoscopic Mucosal Resection) | Sessile lesions 10–20 mm | Submucosal injection lifts lesion; piecemeal if large; surveillance at 3–6 months |
| ESD (Endoscopic Submucosal Dissection) | >20 mm lesions requiring en-bloc resection | Technically demanding; longer procedure; lower recurrence vs piecemeal EMR |
| Balloon Dilation | Crohn's strictures of the colon / ileocolonic anastomosis | Short (<5 cm), fibrostenotic strictures; through-the-scope balloon; fluoroscopy optional |
Clinical Insights & Current Guidelines
BSG / ESGE 2023–2024 Key Updates
- • ESGE 2022 Quality Colonoscopy guideline: ADR ≥25% is a mandatory performance indicator; ADR <15% is a patient safety concern requiring retraining.
- • Bowel preparation: split-dose or day-of preparation is superior to previous day-only; BSG 2022 endorses low-volume preparations (1L + ascorbic acid) as equivalent to 2L or 4L high-volume preparations.
- • AI-assisted colonoscopy (CADe systems): ESGE recommends CADe systems as adjuncts to improve ADR, particularly for right-sided flat lesions. Not yet a substitute for technique.
- • Lynch syndrome: universal MMR testing of all new CRC diagnoses now recommended (BSG/ACPGBI 2020); colonoscopic surveillance every 1–2 years from age 25.
- • Crohn's stricture dilation: short (<5 cm), non-prestenotic, fibrostenotic ileocolonic strictures are suitable for through-the-scope balloon dilation; success rate ~85% at 12 months.
Balloon Dilation in Lower GI Disease
Endoscopic balloon dilation of colonic and ileocolonic strictures in Crohn's disease is a well-established technique that delays or avoids surgery in selected patients. The Amara 3-Stage Balloon Dilator provides progressive, controlled radial force across three sequential stages within a single catheter, reducing the need for multiple device exchanges and allowing the endoscopist to titrate dilation precisely. For anastomotic strictures post-colonic resection, stepwise dilation (typically 15→18→20 mm) minimises perforation risk. High-pressure balloons are required for fibrotic post-inflammatory strictures. Injection of long-acting corticosteroid (triamcinolone) at the stricture margin at time of dilation reduces recurrence in refractory cases.
Single-Use Endoscopes in Lower GI Endoscopy
The lower GI endoscopy landscape is seeing increasing adoption of single-use flexible sigmoidoscopes and colonoscopes, driven by infection control requirements (particularly post-COVID-19), reducing reprocessing burden, and improving access in outpatient and remote settings. Single-use devices eliminate the risk of transmission of prions, biofilm-forming organisms, and emerging pathogens (e.g. CRE) that have been linked to reusable endoscope channels despite high-level disinfection. Envaste's single-use scope portfolio supports this transition.
Frequently Asked Questions: Lower GI Diseases
What are the warning signs of colorectal cancer?
Warning signs of colorectal cancer include rectal bleeding or blood in the stool, a persistent change in bowel habits lasting more than 3 weeks, unexplained weight loss, abdominal pain or bloating, a feeling of incomplete bowel emptying, and iron-deficiency anaemia. These symptoms warrant prompt medical evaluation. Colorectal cancer is highly treatable when detected early — with 5-year survival rates above 90% at stage I.
What is the difference between Crohn's disease and ulcerative colitis?
Both are forms of inflammatory bowel disease (IBD). Crohn's disease can affect any part of the GI tract from mouth to anus, causes transmural (full-thickness) inflammation, and may involve skip lesions, strictures, and fistulae. Ulcerative colitis is confined to the colon and rectum, causes continuous mucosal inflammation always starting at the rectum, and presents with bloody diarrhoea, urgency, and tenesmus. Colonoscopy with biopsy is essential for diagnosis and differentiation.
How often should I have a colonoscopy for cancer screening?
For average-risk individuals, colonoscopy screening is typically recommended from age 45–50 (depending on national guidelines). If no polyps are found, the next colonoscopy is recommended in 10 years. Individuals with adenomatous polyps require earlier surveillance (1–3 years depending on size and number). Those with a family history of colorectal cancer, Lynch syndrome, FAP, or long-standing IBD may need screening from a younger age and more frequently.
What is a colonoscopy and what happens during the procedure?
A colonoscopy uses a thin, flexible camera (colonoscope) passed through the rectum to examine the entire colon. It is performed under mild sedation. The day before, bowel preparation (a laxative solution) is taken to empty the colon. During the procedure, the endoscopist visualises the colonic mucosa, takes biopsies, and removes polyps immediately via polypectomy. The procedure takes 20–45 minutes. CT colonography (virtual colonoscopy) is a non-invasive alternative for patients unable to undergo optical colonoscopy.
Can balloon dilation treat IBD strictures without surgery?
Yes — endoscopic balloon dilation is a well-established treatment for short (<5 cm), fibrostenotic ileocolonic and anastomotic strictures in Crohn's disease. A balloon catheter is passed through the colonoscope and inflated to gradually widen the narrowed segment. Success rates reach approximately 85% at 12 months. It avoids or delays surgery in selected patients. High-pressure balloons are used for fibrotic strictures, and corticosteroid injection at the time of dilation can reduce recurrence in refractory cases.